Massimilano Colao - Net Worth and Insider Trading
Massimilano Colao Net Worth
The estimated net worth of Massimilano Colao is at least $110,389 dollars as of 2024-11-13. Massimilano Colao is the Chief Commercial Officer of Aurinia Pharmaceuticals Inc and owns about 13,495 shares of Aurinia Pharmaceuticals Inc (AUPH) stock worth over $110,389. Details can be seen in Massimilano Colao's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Massimilano Colao has not made any transactions after 2022-03-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Massimilano Colao
Massimilano Colao Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Massimilano Colao owns 1 companies in total, including Aurinia Pharmaceuticals Inc (AUPH) .
Click here to see the complete history of Massimilano Colao’s form 4 insider trades.
Insider Ownership Summary of Massimilano Colao
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AUPH | Aurinia Pharmaceuticals Inc | 2022-03-02 | Chief Commercial Officer |
Massimilano Colao Latest Holdings Summary
Massimilano Colao currently owns a total of 1 stock. Massimilano Colao owns 13,495 shares of Aurinia Pharmaceuticals Inc (AUPH) as of March 2, 2022, with a value of $110,389.
Latest Holdings of Massimilano Colao
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AUPH | Aurinia Pharmaceuticals Inc | 2022-03-02 | 13,495 | 8.18 | 110,389 |
Holding Weightings of Massimilano Colao
Massimilano Colao Form 4 Trading Tracker
According to the SEC Form 4 filings, Massimilano Colao has made a total of 1 transactions in Aurinia Pharmaceuticals Inc (AUPH) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Aurinia Pharmaceuticals Inc is the sale of 3,205 shares on March 2, 2022, which brought Massimilano Colao around $38,492.
Insider Trading History of Massimilano Colao
- 1
Massimilano Colao Trading Performance
Massimilano Colao Ownership Network
Ownership Network List of Massimilano Colao
Ownership Network Relation of Massimilano Colao
Massimilano Colao Owned Company Details
What does Aurinia Pharmaceuticals Inc do?
Who are the key executives at Aurinia Pharmaceuticals Inc?
Massimilano Colao is the Chief Commercial Officer of Aurinia Pharmaceuticals Inc. Other key executives at Aurinia Pharmaceuticals Inc include Chief Commercial Officer Scott Michael Habig , director & Chief Executive Officer Peter Greenleaf , and Chief Financial Officer Joseph M Miller .
Aurinia Pharmaceuticals Inc (AUPH) Insider Trades Summary
Over the past 18 months, Massimilano Colao made no insider transaction in Aurinia Pharmaceuticals Inc (AUPH). Other recent insider transactions involving Aurinia Pharmaceuticals Inc (AUPH) include a net sale of 51,893 shares made by Scott Michael Habig , a net sale of 30,076 shares made by Volker Knappertz , and a net sale of 13,679 shares made by Jayne David R.w. .
In summary, during the past 3 months, insiders sold 9,798 shares of Aurinia Pharmaceuticals Inc (AUPH) in total and bought 0 shares, with a net sale of 9,798 shares. During the past 18 months, 397,215 shares of Aurinia Pharmaceuticals Inc (AUPH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 397,215 shares.
Aurinia Pharmaceuticals Inc (AUPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aurinia Pharmaceuticals Inc Insider Transactions
Massimilano Colao Mailing Address
Above is the net worth, insider trading, and ownership report for Massimilano Colao. You might contact Massimilano Colao via mailing address: #1203-4464 Markham Street, Victoria A1 Bc V8z7x8.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
